BRIEF-AstraZeneca Says FDA Authorises Restart Of COVID-19 Vaccine Trial in U.S.

AstraZeneca PLC: * FDA AUTHORISES RESTART OF COVID-19 AZD1222 VACCINE US PHASE III TRIA

* FOOD AND DRUG ADMINISTRATION (FDA) AUTHORISED RESTART OF TRIAL IN US * FDA REVIEWED ALL SAFETY DATA FROM TRIALS GLOBALLY AND CONCLUDED IT WAS SAFE TO RESUME TRIAL. Further company coverage: